XMD-12 is a selective pan-Aurora Kinase inhibitor, with an IC50 of 5.6/18.4/24.6 nM for Aurora A/B/C, with anti-tumor activity, and can promote the apoptosis of cancer cells induced by paclitaxel.
Molecular Weight:
430.5
Purity:
99.94%
CAS Number:
[1234481-08-3]
Formula:
C24H26N6O2
Target:
Aurora Kinase
T71169
T71169
* VAT and and shipping costs not included. Errors and price changes excepted